Group of Alkaloids, the Novel Autophagic Enhancers for Treatment of Cancers and Neurodegenerative Conditions Thereof
AssigneeMacau University of Science and Technology
InventorsKam Wai WONG, Yuen Kwan LAW, Liang LIU, Jingrong WANG
Life of this patent
Estimating the term…
Abstract
The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
Claims8
A method of treating neurodegenerative disorder comprising administering an effective amount of an alkaloid to a subject in need thereof, wherein said alkaloid is biscoclaurine alkaloid.
The method of claim 18 wherein said biscoclaurine alkaloid is cepharanthine.
A pharmaceutical composition for treating neurodegenerative disorder comprising an alkaloid, wherein said alkaloid is biscoclaurine alkaloid.
Dependencies are inferred from the claim text.